中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月8日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (24): 95-98    
  检验医学 本期目录 | 过刊浏览 | 高级检索 |
血清铁蛋白、谷氨酰转肽酶、腺苷脱氨酶和5′-核苷酸酶联合检测对肝癌的诊断价值
乔荔 李明
新疆医科大学附属中医医院检验科,新疆乌鲁木齐 830000
Diagnostic value of combined detection of serum ferritin, glutamyl transpeptidase, adenosine deaminase and 5′-nucleotidase in liver cancer
QIAO Li LI Ming
Department of Laboratory, Xinjiang Medical University Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Uygur Autonomous Region, Urumqi 830000, China
全文: PDF (458 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 研究血清铁蛋白(SF)、谷氨酰转肽酶(GGT)、腺苷脱氨酶(ADA)和5′-核苷酸酶(5′-NT)联合检测对肝癌的诊断价值。 方法 选取2020年4月至2022年3月于新疆医科大学附属中医医院治疗的200 例肝癌患者作为肝癌组, 选取同期195 例肝良性肿瘤患者作为良性组。 采集两组空腹静脉血4 ml, 测定并比较两组患者的SF、GGT、ADA 及5′-NT 水平,以病理诊断结果作为金标准,计算SF、GGT、ADA 及5′-NT 单项及联合诊断肝癌的一致性及敏感度、特异度、准确度。 结果 肝癌组患者的SF、GGT、ADA 及5′-NT 水平高于良性组,差异有统计学意义(P<0.05)。 以病理诊断结果作为金标准,SF+GGT+ADA+5′-NT 诊断肝癌结果与病理结果的一致性优于SF、GGT、ADA 及5′-NT。 SF+GGT+ADA+5′-NT 联合诊断的敏感度、准确度高于SF、GGT、ADA 及5′-NT 单项检测结果,差异有统计学意义(P<0.005);SF、GGT、ADA 及5′-NT 单项及联合诊断肝癌的特异度比较,差异无统计学意义(P>0.005);SF、GGT、ADA 及5′-NT 单项检测的敏感度及特异度、准确度比较,差异无统计学意义(P>0.005)。 结论 肝癌患者的血清SF、GGT、ADA 和5′-NT 水平升高,且联合检测SF、GGT、ADA 和5′-NT 能够提高肝癌诊断敏感度,诊断效能较高。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 肝癌铁蛋白谷氨酰转肽酶腺苷脱氨酶5&prime-核苷酸酶诊断效能    
Abstract:Objective To study the diagnostic value of serum ferritin (SF), glutamyltranspeptidase (GGT), adenosine deaminase (ADA) and 5′-nucleotidase (5′-NT) in the diagnosis of liver cancer. Methods A total of 200 patients with liver cancer treated in Xinjiang Medical University Affiliated Hospital of Traditional Chinese Medicine from April 2020 to March 2022 were selected as the liver cancer group, and 195 patients with benign liver tumors during the same period were selected as the benign group. The levels of SF, GGT, ADA and 5′-NT were measured and compared between the two groups. The pathological diagnosis results were used as the gold standard to calculate the consistency, sensitivity, specificity and accuracy of SF, GGT, ADA and 5′-NT in single and combined diagnosis of liver cancer. Results The levels of SF, GGT, ADA and 5′-NT in liver cancer group were higher than those in benign group, and the differences were statistically significant (P<0.05). Taking pathological diagnosis results as the gold standard, the consistency between SF+GGT+ADA+5′-NT and pathological results was better than that of SF, GGT, ADA and 5′-NT. The sensitivity and accuracy of SF+GGT+ADA+5′-NT combined diagnosis were higher than those of SF, GGT, ADA and 5′-NT alone,the differences were statistically significant (P<0.005). There was no statistically significant difference in the specificity of SF, GGT, ADA and 5′-NT in the diagnosis of hepatocellular carcinoma (P>0.005). There were no statistically significant differences in the sensitivity, specificity and accuracy of SF, GGT, ADA and 5′-NT (P>0.005). Conclusion The serum levels of SF, GGT, ADA and 5′-NT in patients with liver cancer are increased, and the combined detection of SF, GGT, ADA and 5′-NT can improve the diagnostic sensitivity of liver cancer, and the diagnostic efficiency is high.
Key wordsLiver cancer    Ferritin    Glutamyl transpeptidase    Adenosine deaminase    5′-nucleotidase    Diagnostic efficiency
    
引用本文:   
乔荔 李明. 血清铁蛋白、谷氨酰转肽酶、腺苷脱氨酶和5′-核苷酸酶联合检测对肝癌的诊断价值[J]. 中国当代医药, 2022, 29(24): 95-98.
QIAO Li,LI Ming. Diagnostic value of combined detection of serum ferritin, glutamyl transpeptidase, adenosine deaminase and 5′-nucleotidase in liver cancer. 中国当代医药, 2022, 29(24): 95-98.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I24/95
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载